SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1

In the past few decades, advances in the outcomes of patients suffering from pancreatic ductal adenocarcinoma (PDAC) have lagged behind these gained in the treatment of many other malignancies. Although the pivotal role of the SUMO pathway in PDAC has been illustrated, the underlying molecule driver...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiao, Li, Jian-Hui, Xu, Long, Li, Ya-Xiong, Zhu, Xiao-Xu, Wang, Xi-Yu, Wu, Xingmei, Zhao, Wei, Ni, Xuhao, Yin, Xiao-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307871/
https://www.ncbi.nlm.nih.gov/pubmed/37188742
http://dx.doi.org/10.1038/s41418-023-01175-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307871/
https://www.ncbi.nlm.nih.gov/pubmed/37188742
http://dx.doi.org/10.1038/s41418-023-01175-4

Ejemplares similares